StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a report released on Thursday. The brokerage issued a hold rating on the medical device company’s stock.
Avinger Trading Down 2.0 %
Avinger stock opened at $0.95 on Thursday. Avinger has a 12 month low of $0.83 and a 12 month high of $5.89. The stock has a fifty day simple moving average of $1.06 and a two-hundred day simple moving average of $2.00. The firm has a market cap of $1.62 million, a price-to-earnings ratio of -0.05 and a beta of 1.17.
Avinger (NASDAQ:AVGR – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The medical device company reported ($2.82) EPS for the quarter, missing the consensus estimate of ($0.43) by ($2.39). The company had revenue of $1.85 million during the quarter, compared to the consensus estimate of $2.55 million. On average, equities research analysts forecast that Avinger will post -4.69 EPS for the current fiscal year.
Institutional Investors Weigh In On Avinger
About Avinger
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Featured Articles
- Five stocks we like better than Avinger
- Ride Out The Recession With These Dividend KingsĀ
- Is Spotify Stock Poised to Soar? Options Traders Think So
- CD Calculator: Certificate of Deposit Calculator
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.